Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Jun
04
Today In Oncology
Annual Galleri Screening Reduced Stage IV Cancer Diagnoses but Missed Primary Endpoint in First Randomized MCED Trial
GLP-1 RAs Associated With Lower Breast Cancer Incidence
American Cancer Society Updates Colorectal Cancer Screening Guideline
Long-Term Follow-Up of Three First-Line Regimens in Mantle Cell Lymphoma
Does Tissue TMB Outperform Blood-Based Testing for Predicting Immunotherapy Response
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo